These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37354505)

  • 1. Lipid Profile as an Indicator of Severity in Cirrhosis of Liver: Hospital based Cross-sectional Study.
    Yamuna J; Akila A; Muruganandam VU; Sivakumar K; Natarajan K; Muruganathan A
    J Assoc Physicians India; 2023 Mar; 71(3):11-12. PubMed ID: 37354505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis.
    Feng R; Guo X; Kou Y; Xu X; Hong C; Zhang W; An Y; Philips CA; Mancuso A; Qi X
    Postgrad Med; 2021 Aug; 133(6):626-638. PubMed ID: 33993838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of serum lipid profile in chronic Hepatitis B patients at a Tertiary Care Centre in Western India: A cross-sectional study.
    Meena DS; Kumar D; Garg MK; Meena M; Seju B; Bohra GK; Midha NK; Banerjee M
    Ann Afr Med; 2022; 21(4):316-321. PubMed ID: 36412329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.
    Kim JJ; Kim JH; Koo JK; Choi YJ; Ko SY; Choe WH; Kwon SY
    Clin Mol Hepatol; 2014 Mar; 20(1):47-55. PubMed ID: 24757658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.
    Cicognani C; Malavolti M; Morselli-Labate AM; Zamboni L; Sama C; Barbara L
    Arch Intern Med; 1997 Apr; 157(7):792-6. PubMed ID: 9125012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIPID PROFILE OF CIRRHOTIC PATIENTS AND ITS ASSOCIATION WITH PROGNOSTIC SCORES: a cross-sectional study.
    Bassani L; Fernandes SA; Raimundo FV; Harter DL; Gonzalez MC; Marroni CA
    Arq Gastroenterol; 2015; 52(3):210-5. PubMed ID: 26486289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein cholesterol is a predictor of survival in cirrhotic patients with acute gastrointestinal bleeding: a retrospective study.
    Cheng R; Tan N; Kang Q; Luo H; Chen H; Pan J; Han Y; Yang Y; Xu X
    BMC Gastroenterol; 2020 Nov; 20(1):381. PubMed ID: 33198637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital.
    Tauseef A; Zafar M; Rashid B; Thirumalareddy J; Chalfant V; Farooque U; Mirza M
    Cureus; 2020 Oct; 12(10):e11019. PubMed ID: 33214947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.
    Gao B; Xiao J; Zhang M; Zhang F; Zhang W; Yang J; He J; Liu Y; Zou X; Xu P; Zhuge Y
    Lipids Health Dis; 2019 Mar; 18(1):79. PubMed ID: 30927926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cholesterol: could it be a sixth parameter of Child-Pugh scoring system in cirrhotics due to viral hepatitis?
    Abbasi A; Bhutto AR; Butt N; Lal K; Munir SM
    J Coll Physicians Surg Pak; 2012 Aug; 22(8):484-7. PubMed ID: 22868011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of family history of metabolic traits on severity of non-alcoholic steatohepatitis related cirrhosis: A cross-sectional study.
    Bhadoria AS; Kedarisetty CK; Bihari C; Kumar G; Jindal A; Bhardwaj A; Shasthry V; Vyas T; Benjamin J; Sharma S; Sharma MK; Sarin SK
    Liver Int; 2017 Sep; 37(9):1397-1404. PubMed ID: 28231412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of high-density lipoprotein cholesterol in patients with decompensated cirrhosis: a propensity score matching analysis.
    Cui B; Guo G; Hui Y; Wang X; Liu W; Sun C
    J Clin Lipidol; 2022; 16(3):325-334. PubMed ID: 35398041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous Ascitic Fluid Infection: Are we Experiencing an Epidemiological shift in Causative Organisms?
    Mehta N; Siddiqui A; Rathi P; Banka N; Mandot A; Somani V; Aherrao N
    J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients.
    Arain SQ; Talpur FN; Channa NA; Ali MS; Afridi HI
    Lipids Health Dis; 2017 Mar; 16(1):51. PubMed ID: 28249586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between lipid profile and severity of liver damage in cirrhotic patients.
    Ghadir MR; Riahin AA; Havaspour A; Nooranipour M; Habibinejad AA
    Hepat Mon; 2010; 10(4):285-8. PubMed ID: 22312394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
    Dănulescu RM; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profile in cirrhotic patients and its relation to clinical outcome.
    Boemeke L; Bassani L; Marroni CA; Gottschall CB
    Arq Bras Cir Dig; 2015; 28(2):132-5. PubMed ID: 26176252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.
    Biselli M; Gramenzi A; Lenzi B; Dall'Agata M; Pierro ML; Perricone G; Tonon M; Bellettato L; D'Amico G; Angeli P; Boffelli S; Bonavita ME; Domenicali M; Caraceni P; Bernardi M; Trevisani F
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1388-1397.e1. PubMed ID: 30557740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.